| Marlena Klein, DO | |
|
2339 Route 70 W, Cherry Hill, NJ 08002-3315 | |
| (856) 532-9519 | |
| Not Available |
| Full Name | Marlena Klein |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 2339 Route 70 W, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457871063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MB10791900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
| Holy Redeemer Home Care | Runnemede, NJ | Home health agency |
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper Family Medicine Pc | 4284530197 | 98 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).
MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 2 days ago
| Entity Name | Cooper Physician Offices Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154369510 PECOS PAC ID: 2860396611 Enrollment ID: O20031122000067 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).
MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 2 days ago
| Entity Name | Cooper Family Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649217175 PECOS PAC ID: 4284530197 Enrollment ID: O20080417000457 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).
MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marlena Klein, DO 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Marlena Klein, DO 2339 Route 70 W, Cherry Hill, NJ 08002-3315 Ph: (856) 532-9519 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).
MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).
Amgen today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus Zometa® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases. The study met its primary and secondary endpoints and demonstrated denosumab's superiority over Zometa in delaying or preventing skeletal related events (SREs).
› Verified 2 days ago
Shagufta Ahsan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |